US biotechnology company Illumina is in discussion with authorities after being added to China's unreliable entity list for allegedly breaching fair market rules, Yicai Global reported on Feb. 7, citing the company's spokesperson.
The company was placed on the Chinese Commerce Ministry's list after cutting ties with Chinese firms, a move that affected the firms' legitimate rights and interests, following President Donald Trump's 10% tariff on Chinese imports, the report said.
The spokesperson told Yicai in a statement that Illumina is seeking solutions in its talk with authorities, the report said.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。